Q1 2026 Vafseo® (vadadustat) net product revenues grew to $15.8 million; Q1 2026 total net product revenues of $52.0 millionNumber of patients ...
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the publication of a post-hoc win ...
AST SpaceMobile shares fell Monday after a satellite launched by Blue Origin was seen as a failure, which could be a setback for the company’s plans to offer satellite-internet services. On Sunday, a ...
Blue Origin acknowledged the satellite was placed into a lower-than-planned orbit, but hasn't commented since it was deemed lost. Analysts expect limited impact on AST SpaceMobile's finances, but ...
AST SpaceMobile (ASTS) shares fell 14% in Monday premarket trading after Blue Origin’s (BORGN) New Glenn rocket failed to place a satellite built by the Texas-based company into its intended orbit.
AST SpaceMobile Inc. shares plunged in early trading on Monday after Blue Origin’s flagship New Glenn rocket failed to correctly place a payload it was carrying for the Texas-based satellite ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio, commonly referred to as the DeRitis ratio, serves as an indicator of liver disease severity and has been linked to several ...
AST SpaceMobile stock (NASDAQ:ASTS) – a company developing a low-Earth-orbit (LEO) satellite constellation to provide broadband directly to smartphones – experienced a 14% increase in stock value on ...
December included a "breakthrough moment" for AST SpaceMobile. AST shares more than tripled last year. The stock has continued to surge another 35% higher to start 2026. That excitement grew in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results